Page last updated: 2024-08-20

sesone and thymidine

sesone has been researched along with thymidine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, SE; Barry, ST; Bryce, RA; Cole, C; Douglas, KT; Edwards, PN; Freeman, S; Gbaj, A; Jaffar, M; Luke, RW; Page, KM; Reigan, P; Stratford, IJ1
Bryce, RA; Freeman, S; Gbaj, A; Reigan, P; Stratford, IJ1
Balzarini, J; Camarasa, MJ; De Clercq, E; Esnouf, R; Gamboa, AE; Liekens, S; Neyts, J; Pérez-Pérez, MJ1
Balzarini, J; Camarasa, MJ; De Clercq, E; Degrève, B; Engelborghs, Y; Esnouf, R; Esteban-Gamboa, A; Pérez-Pérez, MJ1
Bera, H; Chui, WK; Dolzhenko, AV; Dutta Gupta, S; Sun, L1
Choudhary, MI; Hameed, A; Ishtiaq, M; Javaid, S; Shaikh, M1

Other Studies

6 other study(ies) available for sesone and thymidine

ArticleYear
Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs.
    Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2

    Topics: Animals; Antineoplastic Agents; Binding Sites; Biological Availability; Escherichia coli; Humans; Imidazoles; Mice; Models, Molecular; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Structure-Activity Relationship; Thymidine Phosphorylase; Uracil

2005
Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:6

    Topics: Enzyme Activation; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Prodrugs; Spectrophotometry, Infrared; Thymidine Phosphorylase; Xanthine Oxidase

2008
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
    FEBS letters, 1998, Oct-30, Volume: 438, Issue:1-2

    Topics: Allantois; Animals; Antibiotics, Antineoplastic; Binding Sites; Bromouracil; Chick Embryo; Chorion; Cyclohexanes; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Escherichia coli; Neovascularization, Physiologic; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Thymidine; Thymidine Phosphorylase; Thymine; Xanthines

1998
Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
    FEBS letters, 2000, Oct-20, Volume: 483, Issue:2-3

    Topics: Bromouracil; Enzyme Inhibitors; Escherichia coli; Kinetics; Models, Molecular; Structure-Activity Relationship; Substrate Specificity; Thymidine; Thymidine Phosphorylase; Thymine; Xanthines

2000
Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors.
    Chemical biology & drug design, 2013, Volume: 82, Issue:3

    Topics: Binding Sites; Cell Line, Tumor; Enzyme Inhibitors; Gene Expression; Humans; Kinetics; Matrix Metalloproteinase 9; Molecular Docking Simulation; Protein Structure, Tertiary; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Thermodynamics; Thymidine; Thymidine Phosphorylase; Triazines; Triazoles; Xanthines

2013
Thymidine esters as substrate analogue inhibitors of angiogenic enzyme thymidine phosphorylase in vitro.
    Bioorganic chemistry, 2017, Volume: 70

    Topics: 3T3 Cells; Animals; Enzyme Inhibitors; Escherichia coli; Esters; Humans; Mice; Molecular Docking Simulation; Thymidine; Thymidine Phosphorylase; Xanthines

2017